Find Clinical Trials | Cedars-Sinai

317 results found

Other

Gaucher Registry

To enhance the understanding of the variability, progression, and natural history of Gaucher disease with the ultimate goal of better guiding and assessing therapeutic interventions; To provide the Gaucher medical community with recommendations for monitoring patients ...

Prostate

CSMC, IIT-NANOVELCRO, ph n/a, prostate ca, enumeration and characterization of CTCs

Primary endpoint: To prospectively enumerate CTCs using Nanovelcro technology in patients undergoing specific forms of therapy for prostate cancer. This will allow us to monitor patients responses to these treatments using CTC number as ...

Brain and Nervous System

COG, ANBL1232,Ph3,open label,historical control, non-high risk neuroblastoma

Primary Aims -To eliminate therapy as the initial approach for infants < 12 months of age with small INRG Stage L1 neuroblastoma while maintaining an overall survival OS) of 99%. -To eliminate therapy as the ...

Anus, Bones and Joints, Brain and Nervous System, Breast - ...

CSMC, BB-UOP-42197-BLOOD-BANK, prostate and other cancer specimens

1. Primary Endpoints: o To develop a bank of annotated blood and tissue specimens over the natural history of patients with cancer with a particular emphasis (but not limited to) in prostate cancer 2. Exploratory/Secondary Endpoints: o To assess the ...

Anus, Cervix, Colon, Corpus Uteri, Lip, Oral Cavity and Pharynx ...

Merck Sharp & Dohme Corp., MK-3475-158, KEYNOTE, Ph 2, Multiple Tumor Types, Pembrolizumab

This study focuses on patients diagnosed with an advanced solid tumor that meets specific criteria. The purpose of the study is to evaluate the investigational use of a drug called pembrolizumab (MK-3475), which may help ...